欢迎访问《标记免疫分析与临床》官方网站!
临床研究

厄贝沙坦对2型糖尿病模型大鼠心肌TGF-β1和CTGF表达的影响

展开
  • (恩施州中心医院 内分泌科,湖北 恩施 445000)
罗嘉,主治医师,研究方向:糖尿病。 E-mail:zwj18335172099@163.com

收稿日期: 2015-01-23

  修回日期: 2015-05-28

  网络出版日期: 2015-09-16

The Influence of Irbesartan on Expression of Myocardial TGF- β1 and CTGF in Type 2 Diabetic Rats

Expand
  • (Department of Endocrine, Enshi Central Hospital,Enshi 445000,China)

Received date: 2015-01-23

  Revised date: 2015-05-28

  Online published: 2015-09-16

摘要

摘要:目的 探讨厄贝沙坦对2型糖尿病模型大鼠心肌TGF-β1和CTGF表达的影响。方法 对正常大鼠、糖尿病大鼠和厄贝沙坦给药的糖尿病大鼠进行体重、心脏重量指数、血糖和胰岛素的测定和比较,分析其心肌组织中TGF-β1和CTGF的表达。结果 两组动物3个月和6个月的体重、心脏重量指数、血糖和胰岛素表达的差异具有统计学意义,P<0.05。厄贝沙坦能够降低干预组TGF-β1和CTGF的表达,且差异具有统计学意义,P<0.05。结论 厄贝沙坦对2型糖尿病模型大鼠的心肌组织具有一定的保护作用,值得进一步的探讨和研究。

本文引用格式

罗 嘉,黄 佳,叶 茂 . 厄贝沙坦对2型糖尿病模型大鼠心肌TGF-β1和CTGF表达的影响[J]. 标记免疫分析与临床, 2015 , 22(7) : 669 . DOI: 10.11748/bjmy.issn.1006-1703.2015.07.025

Abstract

Abstract:Objective To explore the influence of irbesartan on the expression of myocardial TGF-β1 and CTGF in type 2 diabetic rats. Methods The blood glucose,insulin, body weight, and heart weight index in type 2 diabetic rats and healthy controls were determined. The expression of myocardium TGF- beta 1 and CTGF in type 2 diabetic rats after treated with irbesartan were analyzed Results There were significantly difference on body weight, heart weight index, blood glucose and insulin between type 2 diabetic rats with and without irbesartan treatment (P < 0.05). The expression of TGF-β1 and CTGF in type 2 diabetic rats with irbesartan intervention were statistical lower that of without irbesartan intervention (P < 0.05). Conclusion Irbesartan could have a protective effect on myocardial tissue of type 2 diabetic rats, and it is worth for further study.
Options
文章导航

/